170 related articles for article (PubMed ID: 27836178)
1. Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.
de Almeida SM; Rotta I; Ribeiro CE; Smith D; Wang R; Judicello J; Potter M; Vaida F; Letendre S; Ellis RJ;
J Neuroimmunol; 2016 Dec; 301():41-48. PubMed ID: 27836178
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
[TBL] [Abstract][Full Text] [Related]
3. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
Adewumi OM; Dukhovlinova E; Shehu NY; Zhou S; Council OD; Akanbi MO; Taiwo B; Ogunniyi A; Robertson K; Kanyama C; Hosseinipour MC; Swanstrom R
AIDS Res Hum Retroviruses; 2020 Jun; 36(6):490-500. PubMed ID: 31914800
[TBL] [Abstract][Full Text] [Related]
5. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
[TBL] [Abstract][Full Text] [Related]
6. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
[TBL] [Abstract][Full Text] [Related]
7. Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.
Calcagno A; Romito A; Atzori C; Ghisetti V; Cardellino C; Audagnotto S; Scarvaglieri E; Lipani F; Imperiale D; Di Perri G; Bonora S
J Neuroimmune Pharmacol; 2017 Mar; 12(1):187-193. PubMed ID: 27826896
[TBL] [Abstract][Full Text] [Related]
8. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
Sturdevant CB; Joseph SB; Schnell G; Price RW; Swanstrom R; Spudich S
PLoS Pathog; 2015 Mar; 11(3):e1004720. PubMed ID: 25811757
[TBL] [Abstract][Full Text] [Related]
9. Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.
de Almeida SM; Oliveira MF; Chaillon A; Rotta I; Ribeiro CE; de Pereira AP; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2018 Dec; 24(6):786-796. PubMed ID: 30194587
[TBL] [Abstract][Full Text] [Related]
10. Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S
J Neurovirol; 2016 Feb; 22(1):88-92. PubMed ID: 26246357
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.
Suh HS; Lo Y; Choi N; Letendre S; Lee SC
J Neuroinflammation; 2015 Apr; 12():72. PubMed ID: 25890304
[TBL] [Abstract][Full Text] [Related]
12. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood.
Ellis RJ; Peterson SN; Li Y; Schrier R; Iudicello J; Letendre S; Morgan E; Tang B; Grant I; Cherner M
Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32554630
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
14. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
[TBL] [Abstract][Full Text] [Related]
15. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
16. The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.
Yuan L; Liu A; Qiao L; Sheng B; Xu M; Li W; Chen D
Biomed Res Int; 2015; 2015():506872. PubMed ID: 25821806
[TBL] [Abstract][Full Text] [Related]
17. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
Schnell G; Price RW; Swanstrom R; Spudich S
J Virol; 2010 Mar; 84(5):2395-407. PubMed ID: 20015984
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood-brain barrier damage.
Bavaro DF; Calamo A; Lepore L; Fabrizio C; Saracino A; Angarano G; Monno L
Infection; 2019 Jun; 47(3):441-446. PubMed ID: 30649685
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
20. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
